Lord James O’Shaughnessy, Senior Partner at Newmarket Strategy, and Piers Ricketts, CEO of Eastern AHSN, reflect on a recent conversation A few weeks ago we jointly hosted a webinar,…
With the ground-breaking approval last month of the life-extending drug combination, palbociclib (a blockbuster monotherapy) with fulvestrant, for patients with advanced breast cancer,[1] as well as other recent combination therapy…
A step in the right direction This week the UK government published its first ever Women’s Health Strategy. The ambition to tackle the gender health gap, which results in women…
As absolutely no one has failed to notice, the coronavirus pandemic has injected new energy into the digital transformation agenda. Incoming NHS Transformation Director Tim Ferris has continued to focus…
On 29th June, A plan for digital health and social care was released by the Department of Health and Social Care. The goal of the plan is to create a…
At Newmarket Strategy, we work with a range of NHS organisations, partners, and suppliers on the elective recovery challenge. As the NHS approaches its first delivery milestone (eradicating >104wk waits)…
Patient and public involvement and engagement means that “activities and research are carried out ‘with’ or ‘by’ members of the public or patients, rather than ‘to’, ‘about’ or ‘for’ them”[1].…
One of the wins to come out of the recent NICE methods review, according to Industry and others in the Life Sciences ecosystem, was the introduction of the severity modifier.[i]…